Milestone Pharmaceuticals Inc. (MIST) Latest Filing Signal
Cross-checked across multiple AI analysts and grounded in the latest SEC filing.
powered by: earningsVibe.ai
Question:
What is the latest filing signal for Milestone Pharmaceuticals Inc.?
Answer:
Based on earningsVibe SuperAnalyst™ synthesis of the latest
10-K, Milestone Pharmaceuticals Inc.'s filing signal
turned positive.
earningsVibe SuperAnalyst™ Verdict:
TURNED POSITIVE
Signal Performance — Stock Price Since Filing
30-Day Change
Pending
from filing date
60-Day Change
Pending
from filing date
Underlying analyst views from Perplexity, Gemini, Claude, and ChatGPT
PERPLEXITY
Turned Positive
GEMINI
Turned Positive
CLAUDE
Turned Positive
CHATGPT
Turned Positive
Unlock the Full Filing Analysis
See full earningsSig™ and risksSig™ analysis across 5,000+ companies
Get Started Free →No credit card required
Question:
What does Milestone Pharmaceuticals Inc. actually do?
Answer:
Milestone Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing cardiovascular medicines. Its lead product, CARDAMYST (etripamil) nasal spray, received FDA approval on December 12, 2025, for the self-administered treatment of paroxysmal supraventricular tachycardia (PSVT) and became available in Q1 2026. The company is also developing etripamil for atrial fibrillation with rapid ventricular rate (AFib-RVR). Milestone operates with a global supply chain for etripamil and employs a specialty sales force of approximately 60 representatives targeting healthcare providers who treat PSVT patients in the United States.
Question:
What are Milestone Pharmaceuticals Inc.'s revenue drivers?
Answer:
Revenue is primarily driven by the commercialization of CARDAMYST (etripamil) nasal spray for PSVT in the United States. The company also generates license revenue from its collaboration agreements.
Cut through noisy SEC filings to find the signal faster
Source-grounded filing intelligence with one-click links back to the filing, so you can move faster and verify everything at the source.
Get Started Free →No credit card required